Adient Management
Management criteria checks 4/4
Adient's CEO is Jerome Dorlack, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is $3.83M, comprised of 16.4% salary and 83.6% bonuses, including company stock and options. directly owns 0.18% of the company’s shares, worth $2.63M. The average tenure of the management team and the board of directors is 3.3 years and 6.9 years respectively.
Key information
Jerome Dorlack
Chief executive officer
US$3.8m
Total compensation
| CEO salary percentage | 16.4% |
| CEO tenure | less than a year |
| CEO ownership | 0.2% |
| Management average tenure | 3.3yrs |
| Board average tenure | 6.9yrs |
Recent management updates
Recent updates
Adient (NYSE:ADNT) Has A Somewhat Strained Balance Sheet
Dec 04
Adient: Aggressive Deleveraging Needed To Minimize Impairment Charges
Nov 12Returns On Capital Are Showing Encouraging Signs At Adient (NYSE:ADNT)
Oct 09Adient plc's (NYSE:ADNT) Popularity With Investors Is Clear
Sep 19We Think You Can Look Beyond Adient's (NYSE:ADNT) Lackluster Earnings
Aug 14Earnings Miss: Adient plc Missed EPS And Analysts Are Revising Their Forecasts
Aug 09These 4 Measures Indicate That Adient (NYSE:ADNT) Is Using Debt Extensively
Aug 04Adient (NYSE:ADNT) Shareholders Will Want The ROCE Trajectory To Continue
Jun 27Lacklustre Performance Is Driving Adient plc's (NYSE:ADNT) Low P/S
Jun 12Are Investors Undervaluing Adient plc (NYSE:ADNT) By 36%?
May 26Adient: Consider Financial Prospects And Buyback Yield
May 22Here's Why Adient (NYSE:ADNT) Has A Meaningful Debt Burden
Apr 07Adient (NYSE:ADNT) Shareholders Will Want The ROCE Trajectory To Continue
Mar 20Adient plc's (NYSE:ADNT) Shares Lagging The Industry But So Is The Business
Feb 12Here's Why Adient (NYSE:ADNT) Has A Meaningful Debt Burden
Jan 07Is There An Opportunity With Adient plc's (NYSE:ADNT) 36% Undervaluation?
Dec 20Adient: Product Demand, Strength In Global Automotive Sales To Bolster Future Growth
Dec 15Returns At Adient (NYSE:ADNT) Are On The Way Up
Dec 02Adient: Too Early To Turn Bullish
Sep 26Is There An Opportunity With Adient plc's (NYSE:ADNT) 44% Undervaluation?
Sep 19Adient (NYSE:ADNT) Has A Pretty Healthy Balance Sheet
Aug 29Adient (NYSE:ADNT) Is Experiencing Growth In Returns On Capital
Aug 08Investor Optimism Abounds Adient plc (NYSE:ADNT) But Growth Is Lacking
Jul 24Adient: A Lack Of Catalysts
Jul 17These 4 Measures Indicate That Adient (NYSE:ADNT) Is Using Debt Extensively
May 15Calculating The Intrinsic Value Of Adient plc (NYSE:ADNT)
Apr 27Returns On Capital At Adient (NYSE:ADNT) Paint A Concerning Picture
Apr 06Adient: NIO And Toyota Agreements Positive, But Risks Persist
Feb 17Adient Q1 2023 Earnings Preview
Feb 06Adient (NYSE:ADNT) Has A Somewhat Strained Balance Sheet
Feb 01Is There An Opportunity With Adient plc's (NYSE:ADNT) 29% Undervaluation?
Jan 10These Return Metrics Don't Make Adient (NYSE:ADNT) Look Too Strong
Dec 20Adient: Positive On Earnings Beat And Buyback Program
Nov 08Adient names Jerome Dorlack as CFO
Oct 31Is Adient (NYSE:ADNT) A Risky Investment?
Oct 18With EPS Growth And More, Adient (NYSE:ADNT) Makes An Interesting Case
Sep 08Is Adient plc (NYSE:ADNT) Trading At A 49% Discount?
Aug 18Adient Q3 2022 Earnings Preview
Aug 04CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$18m |
| Jun 30 2024 | n/a | n/a | US$74m |
| Mar 31 2024 | n/a | n/a | US$158m |
| Dec 31 2023 | n/a | n/a | US$213m |
| Sep 30 2023 | US$4m | US$628k | US$205m |
| Jun 30 2023 | n/a | n/a | US$115m |
| Mar 31 2023 | n/a | n/a | US$12m |
| Dec 31 2022 | n/a | n/a | -US$54m |
| Sep 30 2022 | US$3m | US$476k | -US$120m |
| Jun 30 2022 | n/a | n/a | US$795m |
| Mar 31 2022 | n/a | n/a | US$754m |
| Dec 31 2021 | n/a | n/a | US$904m |
| Sep 30 2021 | US$3m | US$420k | US$1b |
| Jun 30 2021 | n/a | n/a | US$112m |
| Mar 31 2021 | n/a | n/a | -US$142m |
| Dec 31 2020 | n/a | n/a | -US$230m |
| Sep 30 2020 | US$4m | US$480k | -US$547m |
| Jun 30 2020 | n/a | n/a | -US$515m |
| Mar 31 2020 | n/a | n/a | -US$511m |
| Dec 31 2019 | n/a | n/a | -US$641m |
| Sep 30 2019 | US$3m | US$523k | -US$491m |
Compensation vs Market: Jerome's total compensation ($USD3.83M) is below average for companies of similar size in the US market ($USD5.51M).
Compensation vs Earnings: Jerome's compensation has been consistent with company performance over the past year.
CEO
Jerome Dorlack (43 yo)
less than a year
Tenure
US$3,826,371
Compensation
Mr. Jerome J. Dorlack has been President, Chief Executive Officer and Director of Adient plc since January 1, 2024. He served as Executive Vice President at Adient plc since 2019 until January 1, 2024 and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$3.83m | 0.18% $ 2.6m | |
| Executive VP | 4.5yrs | US$2.93m | 0.050% $ 720.2k | |
| Executive Vice President of APAC | 5.9yrs | US$2.62m | no data | |
| Executive Vice President of EMEA | 5.9yrs | US$2.55m | 0.086% $ 1.2m | |
| Executive VP & CFO | less than a year | no data | 0.090% $ 1.3m | |
| Senior VP & Chief Accounting Officer | 5.2yrs | no data | 0.015% $ 210.9k | |
| Executive Vice President - Americas | 2yrs | no data | 0.061% $ 878.7k | |
| Executive VP of Global IT & Business Services and Sustainability | 1.9yrs | no data | 0.055% $ 788.8k |
3.3yrs
Average Tenure
54.5yo
Average Age
Experienced Management: ADNT's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$3.83m | 0.18% $ 2.6m | |
| Independent Director | 8.2yrs | US$310.00k | 0.048% $ 685.1k | |
| Independent Director | 8.2yrs | US$310.00k | 0.047% $ 678.5k | |
| Independent Chairman of the Board | 8.2yrs | US$460.00k | 0.090% $ 1.3m | |
| Independent Director | 3.6yrs | US$290.00k | 0.017% $ 246.7k | |
| Independent Director | 6.9yrs | US$290.00k | 0.033% $ 477.8k | |
| Independent Director | 5.8yrs | US$305.00k | 0.044% $ 623.8k | |
| Independent Director | 8.2yrs | US$290.00k | 0.049% $ 696.6k | |
| Independent Director | 1.3yrs | US$8.74k | 0.0073% $ 105.0k |
6.9yrs
Average Tenure
63yo
Average Age
Experienced Board: ADNT's board of directors are considered experienced (6.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 05:34 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Adient plc is covered by 24 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Leiker | Baird |
| Dan Levy | Barclays |
| James Picariello | BNP Paribas Exane |